Taraji P. Henson feels “much better” after calling off her engagement to Kelvin Hayden, whom she was engaged to for two years.
Taraji P. Henson feels “much better” after calling off her engagement to Kelvin Hayden, whom she was engaged to for two years.
The third-largest investor in British housebuilder Countryside on Wednesday called for the company's chairman to be replaced and for its own representative to join the board as part of efforts to break up the company. The move follows previous letters to the board in which U.S.-based Browning West laid out its plan to split off the company's housebuilding arm from the Partnerships unit which helps build social housing alongside local government groups in Britain. Doing so would "enhance outcomes for all of Countryside's stakeholders, as well as ensure that the Company can continue to fulfil its important role in the community by addressing the UK's chronic housing shortage in a sustainable manner," it said.
The diagnostic specialty antibodies market is projected to grow with a CAGR of 5. 95%, during the forecast period. The advancements in DNA based technologies and diagnostics are expected to boost the market growth.New York, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Diagnostic Specialty Antibodies Market - Growth, Trends, and Forecast (2020 - 2025)" - https://www.reportlinker.com/p05993766/?utm_source=GNW In addition, the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world is projected to fuel the market. Furthermore, the increase in the prevalence of diseases such as infectious diseases, influenza and cancer are expected to boost the diagnostic antibodies market.However, the high cost of development of antibodies in rapid diagnosis are expected to hamper the market growth. Moreover, the launch of new products and innovations in the diagnostic technologies is projected to boost the market. For instance, in August 2018, BioGenex has launched a range of antibodies that are used for cancer diagnosis.Key Market TrendsMonoclonal Antibodies are Expected to have Significant Growth Rate- Monoclonal antibodies play a vital role in the diagnosis of many infectious and chronic diseases such as cancer. The increase in the number of research on the monoclonal antibodies and its applications in various disease diagnosis are expected to boost the segment revenue.- Among the application segments, oncology application is anticipated to have a significant growth rate owing to recent drug approvals, a notable number of pipeline products and their expected commercialization.- For instance, in April 2017, Roche launched the monoclonal antibody for diagnosis of prostate cancer.- A growing number of cancer cases coupled with increasing awareness regarding the early diagnosis are expected to bolster the cancer application segment growth over the period.North America is Projected to Have Significant Market GrowthNorth America is projected to have a significant market share among the regions owing to the adaptation of various antibody diagnostics coupled with well-established healthcare infrastructure in the region. In addition, new product launches, high R&D investments and the growing number of cancer cases are some of the factors that are fuelling the market growth in this region. Moreover, the favorable government policies and increased funding from the government in cancer research expected to bolster the market growth. Due to the rising incidence of lifestyle-related diseases, cancer and infectious diseases in emerging countries of Asia-Pacific are expected to boost the Asia-Pacific diagnostic speciality antibodies market. According to the World Health Organization, each year cancer causes 7.9 million deaths around the world, of which 5.5 million from developing countries only.Competitive LandscapeThe diagnostic speciality antibodies market is moderately competitive with a notable number of market players. Market players are focusing on new product developments, collaborations and regional expansion to expand their market share. For instance, CytoDyn Inc has licenced its HIV drug leronlimab to IncellDx for diagnostic applications. The key market players operating in urgent care centres include F. Hoffmann-La Roche AG, Abcam plc, Bio-Rad Laboratories, Inc., Abbott Laboratories and Agilent Technologies, Inc. among others.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p05993766/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
China on Wednesday rejected U.S. accusations it is weakening its enforcement of U.N. sanctions against North Korea, but said more efforts are needed toward reaching a political settlement and greater attention should be paid to the impact of the sanctions on ordinary North Koreans. Foreign ministry spokesperson Hua Chunying was responding to comments by the State Department’s deputy envoy for North Korean affairs, Alex Wong, in which he said China was no longer even attempting to enforce many of the sanctions, including a requirement to expel North Korean contract workers.
Shoppers have been queuing early on what has been dubbed 'Wild Wednesday'.
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Vision Care: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides a detailed analysis of the vision care devices market. This report will highlight the current and future market potential of vision care devices along and provide a detailed analysis of the competitive landscape. The report covers market projections for 2025 along with current market estimates. Epidemiology trends of major eye disorders, drivers, restraints, and opportunities will also be covered in the current report along with company profiles of the key market players. The report segments the market for vision care devices based on device, distribution channel, and geography. Based on device type, the market is broadly segmented into eyeglasses, contact lenses, intraocular lenses (IOLs), and artificial tears. Eyeglasses are further segmented into a single vision, bifocal and progressive. Contact lenses are further segmented into spherical lenses, toric lenses, multifocal contact lenses, and others. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast values for 2025. By geography, the market has been segmented into North America, Europe, the Asia-Pacific region, Latin America, and the Middle East and Africa. Detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia, Brazil, and Mexico will be covered in the regional segments. The Report Includes: 21 data tables and 11 additional tablesA brief overview of the global markets for vision care products and related technologiesAnalyses of the global market trends, with corresponding market analysis data for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025Estimation of the actual market size and revenue forecasts for vision care, and market share analysis on the basis of product type with major regions and countries involvedInsights into the market potential for vision care devices, opportunities and restraints, regulatory updates, and technological trends and issues impacting the industryImpact of COVID-19 pandemic on the vision care marketInformation pertaining to strategic profiling of key companies (manufacturers and distributors) present across the globe and their competitive landscape, product launch strategies, and financial outlookKey merger and acquisition deals, joint ventures, collaborations, agreements, and partnerships within the medical devices industryProfile descriptions of the market-leading participants, including Alcon AG, Bausch + Lomb, Carl Zeiss AG, CooperVision Inc., EssilorLuxottica, and Seiko Opticals Market growth is attributed to factors such as the growing prevalence of blindness and vision impairment, a rise in the world's geriatric population, and growing collaborations between vision care companies and technology companies for the advent of technologically advanced products to address current unmet needs. According to the IAPB, nearly 1.1 billion people are considered to be affected by some form of vision loss: 43 million people are categorized as blind, about 553 million people are estimated to suffer from some form of moderate to severe visual impairment (MVSI), about 258 million people experience mild vision impairment and about 510 million suffer from near vision impairment. In addition, at least 1 billion more people need ongoing access to eye care services. High prevalence and the increasing burden of vision impairment is likely to drive the vision care market during the forecast period. Reasons for Doing This Study: Visual impairment is a global health concern that has a negative impact on both physical and mental wellbeing. Preventive blindness, a common vision disorder, represents a major challenge to the global healthcare system. Visual impairment is associated with loss of global productivity and high disability-adjusted life years (DALYs) and is responsible for significant healthcare spending. According to the International Agency for the Prevention of Blindness (IAPB), in 2020, nearly 1.1 billion people were considered to be affected by some form of vision loss; 43 million people are categorized as blind, about 553 million people are estimated to suffer from some form of Moderate and Severe Vision Impairment MSVI, about 258 million people experience mild vision impairment and about 510 million suffer from near vision impairment. In addition, at least 1 billion more people need ongoing access to eye care services. Globally, the leading causes of vision impairment are uncorrected refractive errors and cataracts. Refractory disorders, particularly myopia, are one of the common ailments seen across all age groups. The incidence of refractory disorders is estimated to have doubled in the last decade compared to past generations, with the rise driven by rapid changes in lifestyles, genetic disorders, and malnutrition. Refractory disorders, although increasingly prevalent, can be treated and are considered preventable ailments if addressed quickly. Market growth has been spurred by the introduction of technologically advanced products and the rise in the global visually impaired population. This report is designed to provide the reader with a background on vision care products, an analysis of the current factors influencing the market, and the tools to make decisions regarding expansion and penetration in this market. Key Topics Covered: Chapter 1 Introduction Study Goals and ObjectivesReasons for Doing This StudyScope of ReportInformation SourcesMethodologyGeographic BreakdownAnalyst's CredentialsCustom ResearchRelated Research Reports Chapter 2 Summary and Highlights Highlights of the Market for Vision Care Chapter 3 Clinical Overview Overview of Vision FunctionsVision Impairment OutlookCauses of Vision ImpairmentOverview of Common Eye ConditionsMyopiaHyperopiaAstigmatismPresbyopiaCataractsDry Eye Chapter 4 Epidemiological Insights Vision Impairment and BlindnessGlobal Estimates of Vision Impairment and BlindnessRegional Estimates of Vision Impairment and Blindness Chapter 5 Supply Chain Overview Supply Chain AnalysisRaw Materials SuppliersProduct ManufacturersProduct DistributorsRetailersEnd Consumers Chapter 6 Vision Care Market Dynamics Market DriversRise in Geriatric Population and Vision DisordersIncrease in Uptake of a New Generation of Contacts LensesRise in Volume of Cataract SurgeriesSoaring Screen Time and Increasing Incidence of Computer Vision SyndromeMarket RestraintsDearth in Eye Care Health Personnel and Low Affordability in Emerging CountriesIncreasing Surgical Procedures for Permanent Vision CorrectionHigh Threat of Counterfeit ProductsMarket TrendsInnovation of Personalized and 3D-Printed Spectacle LensesAdvent of Smart Eyeglasses and Smart Contact LensesIntensification of E-commerce as Preferred Distribution Channel Chapter 7 Impact of COVID-19 Pandemic on the Vision Care Market IntroductionSeverity of the DiseaseCOVID-19's Implications on the Vision Care IndustryMomentary Halt in Product ManufacturingTemporary Closure of Retail OutletsDelays in Elective Surgical ProceduresCancellation/Postponement of Eye ExamsTrade Restrictions and Supply DisruptionsOutline of COVID-19's Impact on the Vision Care MarketPossible Post-COVID-19 Vision Care Market Scenario Chapter 8 Market Breakdown by Product Type Global Market for Vision Care, by Product TypeEyeglass LensesMarket Size and ForecastMarket Analysis by RegionMarket Analysis by Product DesignContact LensesMarket Size and ForecastMarket Analysis by RegionMarket Analysis by Product DesignIntraocular LensesMarket Size and ForecastMarket Analysis by RegionOther Vision Care ProductsMarket Size and Forecast Chapter 9 Market Breakdown by Region Global Market for Vision Care, by RegionNorth AmericaMarket Size and ForecastMarket AnalysisMarket Share by CountryEuropeMarket Size and ForecastMarket AnalysisMarket Share by CountryAsia-PacificMarket Size and ForecastMarket AnalysisMarket Share by CountryLatin AmericaMarket Size and ForecastMarket AnalysisMarket Share by CountryMiddle East and AfricaMarket Size and ForecastMarket Analysis Chapter 10 Competitive Landscape Global Competitive OverviewEyeglass LensesContact LensesIntraocular LensesKey Recent Product Approvals/LaunchesStrategic Deals and Collaborations Chapter 11 Company Profiles AlconBausch + LombCarl ZeissCoopervision Inc.EssilorluxotticaHoya Corp.Johnson & JohnsonMeniconRodenstockSeiko OpticalsSynergeyes Chapter 12 Appendix: Acronyms For more information about this report visit https://www.researchandmarkets.com/r/35ke4b Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Pope Francis condemned on Wednesday the killing of scores of farmers and villagers in northeast Nigeria by suspected Islamist militants as a "terroristic massacre" that offended the name of God. Francis spoke of Saturday's attack during his weekly general audience, held virtually from his library in the Vatican because of the coronavirus pandemic. "I want to assure my prayers for Nigeria, which unfortunately once again has been bloodied by a terroristic massacre," the pope said.
Most UK businesses are planning virtual Christmas parties, gifts and bonuses for staff this holiday season and are expected to spend an average of £225 per employee.
“I’ll take it with you Piers. I think you have to show leadership in these things.”
We stalked a couple of our favourite celebrities who made us wish we were in the snowy mountains or the green ocean instead of being in bed at home.
The Hollywood star said turning 40 had made her think about having children, and so she wanted to get healthy.
The Women's Tennis Association (WTA) will rename its tournament categories from next season to align with the men's ATP, a sign of further collaboration between the tours following a season that was severely disrupted by the COVID-19 pandemic. The global health crisis decimated the 2020 tennis calendar and prompted calls for a merger of the governing bodies, a suggestion that was well received by both the WTA and ATP. The women's tour has comprised of five tiers -- Premier Mandatory, Premier 5, Premier, International and $125K events, while the ATP has Masters 1000, 500, and 250-level tournaments.
The global large volume parenteral (lvp) market is projected to expand at a CAGR of 6. 1% by 2025. Rising number of surgeries, need for a faster route of drug administration, growing preference for single dose administration of vaccines and drugs, and increase in local manufacturing is expected to drive the market for LVP.New York, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Large Volume Parenteral (LVP) Market - Growth, Trends, and Forecast (2020 - 2025)" - https://www.reportlinker.com/p05993767/?utm_source=GNW Increasing patient pool suffering from chronic disease is one of the major drivers in the large volume parenteral market. As per the National Cancer Institute, in 2019, around 1.8 million people diagnosed with cancer in the United States. These patients must need a proper balance of vital nutrients that help in maintaining the hydration level, energy, and strength. Parenteral route of administration helps provide accurate dose of medication as majority of the drug is directly absorbed in circulation, bypassing the gastrointestinal tract. Therefore, target disease act as a vital factor to surge market growth throughout the forecast period.Moreover, individuals and healthcare authorities are paying extensive focus on limiting the mortality rate due to early birth and are thereby propelling the use of large volume parenteral. Ongoing developments in health insurance and medical technology can also boost the pharma industry by eliminating financial and physical barriers to healthcare access, thereby surging the market growth.However, challenges in formulation of large volume parenteral such as achieving drug substance and excipient compatibility may restrict the market.Key Market TrendsThe Nutritious Injections Segment Dominates the Market and is Expected to Continue the Same during the Forecast Period- The nutritious injections by application segment is expected to dominate of the global large volume parenteral market through the forecast period owing to growing applications in the geriatric and pediatric population coupled with its requirement in the management of chronic diseases such as ulcerative colitis and cancer. These patient pool need a continuous nutrition system to fulfill nutrition deficiencies which will pave the way for the segment.- In addition, prevalence of malnutrition is high in the developing countries. As per the WHO, around 45% of deaths among children under 5 years of age are linked to undernutrition. Also, 1.9 billion adults are overweight or obese, while 462 million are underweight. The nutrition injections are crucial in terms of nourishment requirements for physical growth to develop a healthy intellectual capacity which is provided through TPN.- Furthermore, the American Society for Parenteral and Enteral Nutrition (ASPEN) initiate malnutrition awareness week to educate and raise awareness among patients and healthcare providers. The aforementioned factors bode a well for the segment growth.The North America Dominates the Market and is Expected to Continue the Same during the Forecast PeriodNorth America dominated the overall market over the forecast period owing to presence of high research expenditure by government agencies and private entities in the healthcare sector, technologically advanced medical devices, and collaborations among regulatory authorities, medical device industry, and universities. Approximately 740 units of normal saline are utilized every minute in this region which govern the regional growth of the market for large volume parenterals.Moreover, favorable reimbursement policies have led to an increase in the hospital admission that is anticipated to boost the usage rates in this region. The reimbursement scenario is promising for IV nutrition. In the U.S., Medicare covers up to 80% of the expenses of parenteral and enteral nutrition including medical equipment, physician services, and other associated medical services, thereby benefiting the patients.Competitive LandscapeThe market for large volume parenteral is moderately competitive and consists of the global as well as local players. Due to the technological advancements, small and mid-sized companies are focusing on market penetration to grab the market share. The market is witnessing dynamic merger and acquisition activities. Some of the companies which are currently present in the market are B. Braun Melsungen AG, Baxter Healthcare Corporation, Fresenius Kabi AG, Pfizer, Inc. and BML Parenteral Drugs. For instance, in July 2017, Baxter completes acquisition of Claris injectables. This transaction was expected to strengthen the company’s generic injectable medicines portfolio.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p05993767/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The health minister described the approval of the Pfizer vaccine as the ‘beginning of the end’.
European Union regulators have revived guidance to allow banks to grant a new round of loan repayment holidays to coronavirus-hit customers without triggering a big surge in provisioning that would crimp the flow of credit. The European Banking Authority (EBA) said that, due to the second wave of COVID-19 infections, guidance for banks that expired on Sept. 30 was being reactivated until March 31, 2021. As the first set of lockdowns from March closed businesses, banks began granting payment holidays on company loans, mortgages and other types of credit.
Loungers, the operator of the Lounge and Cosy Club café-bar chains, today reported a 33% drop in revenues as its chief executive said the company has been saved from the pandemic's worst impacts by its suburban and market town base. In Loungers' results statement, chief executive Nick Collins labelled the Tiers restrictions "bewildering" and "unfair" and said the Government's "ill-thought through policies... have brought much of our industry to its knees".
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "BPO Business Analytics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global BPO business analytics market grew at a CAGR of around 25% during 2014-2019. Looking forward, the global BPO business analytics market is set to continue its strong growth during the next five years.Business analytics refers to a data management solution that enables organizations to comprehend potential customers, make strategic decisions, optimize operational costs, and improve business proficiency and competitiveness. The widespread adoption of advanced technological solutions, such as the internet of things (IoT), machine learning and artificial intelligence (AI), in business processes, has increased the utilization of business analytics to manage large volume and complexity of data sets. Nowadays, organizations are subcontracting their analytics functions to business process outsourcing (BPO) companies or third-party service providers as it helps them to minimize cost on hiring in-house staff and focus on their core business operations.The rising adoption of business analytics in various industry verticals represents one of the key factors spurring the global BPO business analytics market growth. Apart from this, the increasing utilization of business analytics across small and medium-sized enterprises (SMEs), coupled with the escalating number of business start-ups, is bolstering the market growth. Furthermore, the growing traction of cloud-based BPO services on account of their reliability, scalability and agility is also contributing to the growth of the market. Moreover, due to the sudden spread of the coronavirus disease (COVID-19), there is a rise in the demand for business analytics in the healthcare industry for efficiently managing the huge volume of hospital data, such as the record of patients and availability of beds. In addition to this, several BPO service providers are adopting different strategies to offer their services online, which is creating a positive outlook for the market. Key Questions Answered in This Report: How has the global BPO business analytics market performed so far and how will it perform in the coming years?What has been the impact of COVID-19 on the global BPO business analytics market?What are the key regional markets?What is the breakup of the market based on the offering?What is the breakup of the market based on the deployment type?What is the breakup of the market based on the application?What is the breakup of the market based on the vertical?What are the various stages in the value chain of the industry?What are the key driving factors and challenges in the industry?What is the structure of the global BPO business analytics market and who are the key players?What is the degree of competition in the industry? Key Topics Covered: 1 Preface2 Scope and Methodology 2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global BPO Business Analytics Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast6 Market Breakup by Offering6.1 Software6.2 Services7 Market Breakup by Deployment Type7.1 Cloud-based7.2 On-premises8 Market Breakup by Application8.1 Finance & Accounting8.2 Human Resources8.3 Knowledge Process Outsourcing8.4 Procurement & Supply Chain8.5 Customer Services9 Market Breakup by Vertical9.1 BFSI9.2 IT and Telecommunication9.3 Healthcare9.4 Manufacturing9.5 Retail9.6 Transportation and Logistics10 Market Breakup by Region11 SWOT Analysis12 Value Chain Analysis13 Porters Five Forces Analysis14 Price Analysis15 Competitive Landscape15.1 Market Structure15.2 Key Players15.3 Profiles of Key Players Accenture PLCCapgemini SEand Cognizant Technology SolutionsExlservice Holdings Inc.Genpact LimitedInternational Business Machines CorporationInfosys LimitedMu Sigma Inc.NTT DATA Corporation (Nippon TelegraphTelephone)TATA Consultancy Services Limited (Tata Sons Private Limited)Tech Mahindra Limited (Mahindra Group)Wipro LimitedWNS Global Services For more information about this report visit https://www.researchandmarkets.com/r/m8xlm Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Euro zone producer prices rose more than expected month-on-month in October and unemployment fell as the economy continued to recover before the second wave of the COVID-19 pandemic struck, data showed on Wednesday. The European Union's statistics office Eurostat said prices at factory gates in the 19 countries sharing the euro rose 0.4% month-on-month for a 2.0% year-on-year decline. Producer prices are an early indication of final prices paid by consumers, which the European Central Bank wants to keep below, but close to 2% over the medium term, but has failed to reach that target for the past eight years.
A daily overview of the top business, market, and economic stories to watch in the UK, Europe, and abroad.
Dr Joseph Varon said patients were battling both COVID and isolation.
Angola's state oil giant Sonangol will next year accelerate reforms and efforts to raise revenue after the pandemic drained investor interest in an asset sale that has so far netted only around $60 million, its CEO told Reuters in a rare interview. Sonangol is the economic engine for Africa's number two oil exporter, as the company and the country strive to move on from decades of alleged corruption under Jose Eduardo dos Santos - president until 2017 - whose daughter once headed Sonangol. In a rare interview with international media, CEO Sebastião Gaspar Martins said the global economic slowdown triggered by COVID-19 had made investors "more conservative".